DeepSyte™
Bill FeedAll repsScoreboardsPrimariesProAboutSign inGet started
DeepSyte™™

A nonpartisan civic accountability tool. We match federal legislation to your stated values — without partisan bias.

Learn

  • About
  • About the name
  • Methodology
  • Glossary

Legal

  • Privacy
  • Terms of Service
  • Refund Policy
  • Contact

Sources

Bill data from Congress.gov. Summaries from the Congressional Research Service where available.

Follow

  • Bluesky — @deepsyte.app
  • X — @deepsyteapp
All content is for informational purposes only. Always verify against primary sources.
Back to bill feed
118-hr-5539Committee
Sign in to get alerts

ORPHAN Cures Act

Read the record. Not the rhetoric.

See how your representatives voted on this bill.

DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.

Get started freeTake the values quiz

Alignment with your views

Sign in and take the values quiz to see how this bill lines up with what you've said.

Summary

AI-generated summary — verify against full text

This bill amends the Social Security Act to expand and clarify how orphan drugs are treated under Medicare's Drug Price Negotiation Program. Specifically, it allows drugs that were previously designated as orphan drugs (used to treat rare diseases) to retain certain protections even after they are no longer classified as orphan drugs, and it expands the definition of orphan drugs to include those treating multiple rare diseases rather than only a single rare disease.

Read full bill text

Values analysis

Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.

Bill details

Congress
118
Bill type
hr
Introduced
September 18, 2023
Sponsor
Not yet available
Last action
December 17, 2024— Referred to the Subcommittee on Health.

How your representatives voted

Sign in to see how your representatives voted on this bill.